Credits Available: 4.75 hours of AMA PRA Category 1 Credit™; ABIM MOC

Description: Welcome to our comprehensive learning program on screening, diagnosing, and managing IgA nephropathy (IgAN). This program aims to provide you with a deep understanding of screening techniques, referral procedures, treatment selection, drug distribution and safety and monitoring requirements in IgAN management. Furthermore, this activity encourages care coordination between interdisciplinary team members to improve the co-management of patients with IgAN.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse Practitioner, Physician Associate/Assistant, Pharmacist
Target Specialties: Nephrology, Family Medicine, Pharmacy

Arvind Madan

CFLKS
Partner /physician

Dr. Madan is an assistant professor of internal medicine at the University of Central Florida (UCF) College of Medicine in Orlando, FL, and an assistant professor at the Orlando College of Osteopathic Medicine in Orlando, FL. He is a partner physician and executive board member ( vice president )at Central Florida Kidney Specialists (CFLKS) in Orlando, FL, and the Director of DaVita Dialysis Unit in Orlando, FL. Dr. Madan is also an attending nephrologist in the residency program at Orlando Regional Hospital System in Orlando, FL. He received his medical degree from Maulana Azad Medical College in New Delhi, India. He completed his residency in internal medicine at Nassau County Medical Center in East Meadow, NY. He then completed his fellowship in nephrology at the State University of New York (SUNY) Health Science Center (HSC) in Syracuse , NY.

Dr. Madan is a principal investigator in numerous clinical trials.
He is the founder and president of NCCF.R ( research division of central fl kidney specialists )
He also serves as a consultant or part of speaker bureau for several pharmaceutical companies such as Otsuka Pharmaceuticals, Mallinckrodt Pharmaceuticals, GSK Pharmaceuticals, Bayer Pharmaceuticals, and Amgen Pharmaceuticals. He is also the author of various publications and posters, some of which he has presented at international congresses such as the 2023 and 2024 European Renal Association congress, 2024 Canadian Society of Nephology congress, 2024 and 2025 National Kidney Foundation (NKF) Spring Meetings, and the 2023 and 2024 American Society of Nephrology (ASN) congress.
Dr. Madan is president of the Florida Society of Nephrology. He is also affiliated with the ASN, NKF, International Society of Nephrology (ISN), and the American Society of Diagnostic and Interventional Nephrology (ASDIN). He is board certified in nephrology and internal medicine.